Matt Miksic

Mako to Acquire Stanmore Robotic Assets in Patent Settlement

Mako Surgical Corp. said it will receive Stanmore Implants Worldwide Ltd.’s robotic business assets and intellectual property in a settlement of a patent dispute.

CareFusion Cash Flow Seen Luring Buyout Firms: Real M&A

CareFusion Corp.’s medical pumps, ventilators and medicine dispensers have already attracted the attention of investors who sent the company’s stock to a record last week. Now, it could get a look from private-equity firms.

Baxter Agrees to Buy Sweden’s Gambro for $2.8 Billion

Baxter International Inc., the world’s second-largest maker of dialysis products, agreed to buy Swedish competitor Gambro AB for 18.3 billion kronor ($2.8 billion) to expand its kidney-equipment business.

Kinetic Luring LBO With Cheapest U.S. Medical Products Valuation: Real M&A

Kinetic Concepts Inc. is enticing private equity firms with the U.S. medical products industry’s cheapest valuation for what would be the biggest leveraged buyout since the collapse of Lehman Brothers Holdings Inc.

Kirkland on Baxter, Baker & McKenzie: Business of Law

Kirkland & Ellis LLP advised Baxter International Inc., the world’s second-largest maker of dialysis products, on an agreement to buy Swedish competitor Gambro AB for 18.3 billion kronor ($2.8 billion) to expand its kidney- equipment business.

J&J Third-Quarter Profit Declines on Generics

Johnson & Johnson, the world’s second-biggest seller of health-care products, said third- quarter profit slipped 6.4 percent as the company spent more to promote new drugs and lost sales to generic competition.

J&J Raises Forecast as Profit Climbs on Demand for Drugs

Johnson & Johnson, the world’s second-biggest maker of health-care products, raised its full- year earnings forecast after quarterly profit climbed on the divestiture of an older drug and revenue from new medicines.

Zimmer, Stryker May Seek Orthopedic Purchases to Keep Pace After J&J Deal

Johnson & Johnson’s newfound dominance of the orthopedic-device market, cemented by its $21.3 billion acquisition of Synthes Inc. , may drive rivals Zimmer Holdings Inc. and Stryker Corp. to seek purchases of their own.

Johnson & Johnson Chief Gorsky Elected to Chairman

Johnson & Johnson, the world’s biggest maker of consumer health products, said Chief Executive Officer Alex Gorsky was elected chairman of the board, succeeding Bill Weldon who will retire next year.

J&J Declines After Revenue Growth Limited by Economy, Generic Competition

Johnson & Johnson, the world’s second-biggest maker of health-care products, declined after sales growth was limited by the faltering economy and generic competition.

"The agreement eliminates the ongoing cost and distraction of litigation, while also strengthening Mako's existing portfolio of intellectual property, particularly in the area of haptics for robotically assisted orthopedic surgery."

- Matt Miksic on Apr 16, 2013

New York

Europe

New Brunswick

Pennsylvania

Bangladesh Starts Manhunt for Building Owner as 340 Killed

Debris From 9/11 Plane Found Between Buildings, NYPD Says

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study

Tesla Model S Tops GM Volt in North American Plug-In Race

Growth in U.S. Trails Forecasts as Defense Spending Falls